75 results
8-K
EX-10.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
to any stock or option plan or arrangement duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority … or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority
8-K
EX-4.1
ke9o xrzdw4r2z4
13 Nov 23
UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
7:00am
8-K
EX-99.2
yl8 bpxy5dl5g
24 Apr 23
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:05am
8-K
EX-99.1
ooxct1 53n0xmtqu
24 Apr 23
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:05am
8-K
EX-99.1
ymi85
1 Nov 22
UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:00am
8-K
EX-99.2
6fusl31 e31
1 Nov 22
UNITY Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:00am
424B5
f9q32g mkln
25 Oct 22
Prospectus supplement for primary offering
9:39pm